These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8297481)
1. Evidence of two separate mechanisms for the decrease in aryl sulfotransferase activity in rat liver during early stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Ringer DP; Howell BA; Norton TR; Woulfe GW; Duffel MW; Kosanke SD Mol Carcinog; 1994 Jan; 9(1):2-9. PubMed ID: 8297481 [TBL] [Abstract][Full Text] [Related]
2. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Ringer DP; Norton TR; Howell BA Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Yerokun T; Etheredge JL; Norton TR; Carter HA; Chung KH; Birckbichler PJ; Ringer DP Cancer Res; 1992 Sep; 52(17):4779-86. PubMed ID: 1511441 [TBL] [Abstract][Full Text] [Related]
4. Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluorene. Ringer DP; Norton TR; Self RR Carcinogenesis; 1992 Jan; 13(1):107-12. PubMed ID: 1733562 [TBL] [Abstract][Full Text] [Related]
5. Modulation of hepatic mRNA translation activity and specific expression of arylsulfotransferase IV during acetylaminofluorene-induced rat hepatocarcinogenesis. Yerokun T; Norton TR; Howell B; Ringer DP Cancer Res; 1991 Jan; 51(2):504-9. PubMed ID: 1670761 [TBL] [Abstract][Full Text] [Related]
6. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites. Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585 [TBL] [Abstract][Full Text] [Related]
7. Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene. Ringer DP; Norton TR; Cox B; Howell BA Cancer Lett; 1988 Jun; 40(3):247-55. PubMed ID: 3164251 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms for the regulation of aryl sulfotransferase IV expression during 2-acetylaminofluorene-induced hepatocarcinogenesis in rat. Ringer DP; Yerokun T; Khan AS Chem Biol Interact; 1994 Jun; 92(1-3):343-50. PubMed ID: 8033268 [TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of the rat aryl sulfotransferase IV gene and amplification of a DNA sequence during multistage 2-acetylaminofluorene hepatocarcinogenesis. Yerokun T; Lyn-Cook BD; Ringer DP Chem Biol Interact; 1994 Jun; 92(1-3):363-70. PubMed ID: 7913417 [TBL] [Abstract][Full Text] [Related]
10. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats. LeBoeuf RA; Laishes BA; Hoekstra WG Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004 [TBL] [Abstract][Full Text] [Related]
11. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene. Mangold BL; Erickson J; Lohr C; McCann DJ; Mangold JB Carcinogenesis; 1990 Sep; 11(9):1563-7. PubMed ID: 2401045 [TBL] [Abstract][Full Text] [Related]
12. Analysis of calcium-dependent protein kinase C isoforms in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis. La Porta CA; Perletti GP; Piccinini F; Comolli R Mol Carcinog; 1993; 8(4):255-63. PubMed ID: 7904165 [TBL] [Abstract][Full Text] [Related]
13. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122 [TBL] [Abstract][Full Text] [Related]
14. Effect of phenobarbital on the gamma-glutamyltranspeptidase activity and the remodeling of nodules induced by the initiation-selection model. Herren-Freund SL; Pereira MA Cancer Lett; 1985 Jun; 27(2):153-61. PubMed ID: 2860967 [TBL] [Abstract][Full Text] [Related]
15. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis. La Porta CA; Comolli R Carcinogenesis; 1995 May; 16(5):1233-8. PubMed ID: 7767990 [TBL] [Abstract][Full Text] [Related]
16. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cattley RC; Popp JA Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380 [TBL] [Abstract][Full Text] [Related]
17. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: immunohistochemical analysis of cytochrome P-450 isozyme induction by 2-acetylaminofluorene and phenobarbital. Asamoto M; Tsuda H; Kato T; Ito N; Masuko T; Hashimoto Y; Nagase S Jpn J Cancer Res; 1989 Nov; 80(11):1041-6. PubMed ID: 2514165 [TBL] [Abstract][Full Text] [Related]
18. Effects of aminothiols in 2-acetylaminofluorene-treated rats. I. Damage and repair of liver DNA, hyperplastic foci, and Zymbal gland tumors. Cesarone CF; Scarabelli L; Orunesu M; Bagnasco M; De Flora S In Vivo; 1987; 1(2):85-91. PubMed ID: 2908770 [TBL] [Abstract][Full Text] [Related]
19. Quercetin and naringenin abate diethylnitrosamine/acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: the roles of oxidative stress, inflammation and cell apoptosis. Ahmed OM; Ahmed AA; Fahim HI; Zaky MY Drug Chem Toxicol; 2022 Jan; 45(1):262-273. PubMed ID: 31665932 [TBL] [Abstract][Full Text] [Related]